Finzati - Logo
QTZM logo

Quantumzyme Corp.

QTZMChemicals - Specialty
Extraordinary move
QTZM+33.33%
vs. previous close $0.60
$0.80
+0.20 (+33.33%)
Current price
EarningsLatest report: Jan 31, 2026
WEAK PROFILEWeakConfidence: 32%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$31.17M
Growth
Cash Flow
Trend
Limited data
Evidence
Weak liquidity · 0Weak profitability
Financial data as of: Jan 31, 2026, 12:00 AM UTCLast earnings update: Jan 31, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.80
Change33.33%
Market Cap$31.17M
Beta7.51
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq-0.57
Current Ratio0.00
Quick Ratio0.00
Volume32.04K
Avg Volume79.68K

Investment DNA

How strong this company looks for long-term investors

22
out of 100
Business Quality
Margins, moat, returns
30/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score
Weak liquidity · 0Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 11/20/2024
Industry: Chemicals - Specialty
P/B i: -23.91
Debt / Equity i: -0.57
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score4 / 20
Debt / Equity: -0.57
Current Ratio: 0.00
Quick Ratio: 0.00
Status: HighRisk

Warnings

  • Weak Liquidity
  • Weak quick ratio
🧾

No insider activity

No recent insider transactions available.